From City Hall and state government to tech, transit and the arts, these figures are poised to shape Austin's year ahead.

Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support global registration in relapsed/refractory chronic ...